The Golden State Storm Powers the Future of Athlete Performance through Flagship Partnership with DOJO Air

The Golden State Storm creates strategic alliance to bring cutting-edge, data-driven breathwork technology to women’s professional football, elevating athlete performance, recovery, and overall health OAKLAND, Calif.–(BUSINESS WIRE)–The Golden State Storm, the San Francisco Bay Area’s premier women’s professional tackle and flag football teams and member of the Women’s National Football Conference (WNFC) is proud to … [Read more…]

KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update

$49.1 million global net product revenue of EKTERLY® (sebetralstat) for the eight months ended December 31, 2025 1,702 patient start forms received in the US from launch through end of February, reflecting continued rapid adoption of first and only oral on-demand treatment for hereditary angioedema (HAE) EKTERLY launched in Japan by partner Kaken Pharmaceutical Co., … [Read more…]

Prestige Medical Group Announces New Woodstock Location, Expanding Access to Care in Cherokee County

WOODSTOCK, Ga.–(BUSINESS WIRE)–Prestige Medical Group, a physician-led healthcare organization serving North Georgia for more than 20 years, announced plans to open a new medical office in Woodstock, Georgia. The new location, opened on March 24, 2026, located at 102 Springfield Center Drive, Woodstock, GA 30188. The Woodstock office represents a strategic expansion of Prestige Medical … [Read more…]

Anumana Named to Fast Company’s 2026 Most Innovative Companies Awards

Recognition highlights Anumana’s leadership in AI-driven cardiovascular detection and clinical decision support CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, a leader in AI-powered cardiovascular detection algorithms, today announced it has been named to Fast Company’s prestigious 2026 Most Innovative Companies list in the Medical Devices category. The annual award recognizes hardware and technologies changing how healthcare is delivered and … [Read more…]

Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association

− Efforts Aimed at Facilitating Earlier Diagnosis, Coordinated Care, and Long-Term Patient Impact in ATTR-CM – − Alnylam to Host TTR Investor Webinar Today at 9:30 am ET – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced a set of strategic efforts designed to accelerate earlier recognition and improve … [Read more…]

Mosaic Therapeutics to Present Poster Highlighting Preclinical Data for Lead Program MOS101 at the American Association for Cancer Research (AACR) Annual Meeting 2026

First preclinical data on the Company’s lead program MOS101: a combination of ASTX295, a next-generation, clinical-stage MDM2 antagonist, and olaparib, an FDA-approved PARP inhibitor, in biomarker-selected solid tumors Additional data showcasing Mosaic’s Discovery Platform, PRIME, will be presented CAMBRIDGE, England–(BUSINESS WIRE)–Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company building the category … [Read more…]

Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases

— Acquisition Adds Clinical Stage Bispecific BCMAxCD3 T Cell Engager with Potential for Durable Immune Reset to Gilead’s Inflammation Portfolio — — Gilead Intends to Enter into a Strategic Collaboration with Galapagos on the Ouro Portfolio of Medicines — FOSTER CITY, Calif.–(BUSINESS WIRE)–#GILD–Gilead Sciences, Inc. (Nasdaq: GILD) announced today it has entered into a definitive … [Read more…]

Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET

Webcast to be held Monday, March 30th, 4:30 p.m. ET, register for the webcast here, or at the link provided below.  DALLAS–(BUSINESS WIRE)–Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning (“ML”) platform with multiple clinical stage drug programs, today … [Read more…]

MaaT Pharma Presents the ARES Phase 3 Pivotal Trial Final Data During the Presidential Plenary Session at the 52nd Annual Meeting of the European Society for Bone and Marrow Transplantation

LYON, France–(BUSINESS WIRE)–$MAAT #ASH–Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer, today announced that Florent Malard, MD, PhD, hematology professor at Saint‑Antoine Hospital and Sorbonne University, presented the final results from … [Read more…]

Priority Health Appoints Brian Steele, D.O., as Chief Medical Officer

GRAND RAPIDS, Mich.–(BUSINESS WIRE)–After a nationwide search, Priority Health, a Michigan-based, nationally recognized nonprofit health plan serving 1.4 million members, has named Brian Steele, D.O., as senior vice president and chief medical officer. He will join Priority Health on April 6, 2026. Dr. Steele will lead Priority Health’s clinical and pharmacy programs, the development and … [Read more…]